For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...
There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...
Researchers emulated target trials comparing recurrence of nephrolithiasis among patients with preexisting nephrolithiasis initiating SGLT-2 inhibitors vs an active comparator. (HealthDay News) — For ...
US nephrologists estimate half of all FSGS patients are not optimally managed, according to Spherix Global Insights.EXTON, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Focal segmental glomerulosclerosis ...
When one is dehydrated, naturally one feels very tired. Certain medicines like SGLT2 inhibitors, (e.g., Dapagliflozin, Empagliflozin) tend to produce excessive urination. If you are on one of these ...
A RECENT real-world study has found that sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are more effective at reducing kidney complications in ...
Also known as selective COX-2 inhibitors, these medications treat inflammatory pain. Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory medication (also known as NSAIDs).
Music by One Direction, including all five of their studio albums, re-entered the Billboard charts this week after fans paid tribute to the late Liam Payne by streaming and purchasing his former ...
"This prognostic imbalance implies, in particular, that any comparison of outcomes between the patients in the empagliflozin group who started an SGLT2 inhibitor post-trial and those in the ...
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity. HealthDay News — From 2010 to 2023, there was an ...
MONDAY, Oct. 28, 2024 (HealthDay News) — From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium glucose cotransporter 2 (SGLT2) ...
MONDAY, Oct. 28, 2024 (HealthDay News) -- From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 ...